跳至主要内容
临床试验/NCT07648420
NCT07648420尚未招募不适用

Feasibility and Usability of the Apollo Neuro, a Wearable Sensory Device, in Autistic Children With Self-Injurious Behavior

Virginia Commonwealth University1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2026年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
18
试验地点
1

研究概览

简要总结

This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB).

Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self- injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.

详细描述

who engage in self-injurious behavior (SIB). Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self-injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
6 Years 至 179 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of autism spectrum disorder (ASD), as reported by caregiver
  • Presence of self-injurious behavior, as reported by caregiver
  • Demonstrates sensory over and/or under- responsivity
  • Aged 6 years to 14 years, 11 months (179 months) at the time of enrollment
  • Has a caregiver willing and able to provide consent and participate in study procedures

排除标准

  • Has medical condition that may increase risk with use of a wearable nibrotactile device, including:
  • implanted medical or neurological devices (e.g., pacemaker)
  • significant cardiac conditions or arrhythmias
  • history of syncope (fainting)
  • Known seizure disorder without physician clearance
  • Regular use of nibrotactile or autonomic- modulating wearable devices within the past 90 days
  • Any condition that, in the judgment of the investigator, would interfere with safe participation or interpretation of study procedures
  • Inclusion Criteria for Caregiver:
  • Parent or legal guardian of the enrolled child participant
  • Able to provide informed consent in English
  • Able and willing to support device use according to study protocol and complete study-related data collection
  • Has access to a smartphone or compatible device capable of operating the Apollo Neuro application for the duration of study period
  • Exclusion Criteria for Caregiver:
  • Unable to provide informed consent in English

研究组 & 干预措施

Apollo Neuro device

Experimental

Wearing of activated Apollo Neuro device for at least three hours/day for 30 of 35 consecutive days by Autistic children with SIB and sensory over and/or under responsivity.

干预措施: Apollo Neuro device (Device)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验